Denise Drace-Brownell is a Senior Advisor at Epsilon Securities. She is also a principal in DDB Technology, a management consulting and restructuring firm, and heads life sciences and pharmaceutical projects. With extensive strategic advisory, M&A, licensing, intellectual property, marketing and transactions experience, she has a track record in solving complex business challenges. She has accomplished profitable growth initiatives, turnarounds, restructuring, and premium sales of companies. Drace-Brownell has held CEO, VP Corporate Development and General Counsel positions for a number of technology organizations, including life sciences and engineering corporations. Earlier she was Practice President of the medical branding unit of McCann Worldgroup, and a corporate attorney in Akzo Nobel’s US M&A unit. Her clients have included Fortune 500s, mid-size, and development stage companies, including J&J, Myriad Genetics and Chevron. Ms. Drace-Brownell holds B.S. from the University of Illinois; a Masters in Public Health (Toxicology) from Columbia University; a J.D. from Rutgers University with advanced work at the University of Pennsylvania; and a fellowship in law and IT from the University of Illinois. She is a member of the Board of Directors of ZS Genetic.
|
| JD Friedland | Bradford C. Burkett | Denise Drace-Browell | Corey Luskin | Brett Goldman | Michael Samra |
140 Broadway, 51st Floor
New York, NY 10005
Phone: (212) 758-0196
Fax: (646) 289-9120